• 1
    Janeway, C. A., Jr. and Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 2002. 20: 197216.
  • 2
    Waage, A., Halstensen, A. and Espevik, T., Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987. 1: 355357.
  • 3
    Girardin, E., Grau, G. E., Dayer, J. M., Roux-Lombard, P. and Lambert, P. H., Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med 1988. 319: 397400.
  • 4
    Webster, J. I., Tonelli, L. and Sternberg, E. M., Neuroendocrine regulation of immunity. Annu. Rev. Immuno.l 2002. 20: 125163.
  • 5
    Scott, W. J. M., The influence of the adrenal glands on resistance. II. The toxic effect of killed bacteria in adrenalectomized rats. J. Exp. Med. 1924. 39: 457471.
  • 6
    Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A. et al., Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 1988. 318: 14811486.
  • 7
    Rothwell, P. M., Udwadia, Z. F. and Lawler, P. G., Cortisol response to corticotropin and survival in septic shock. Lancet 1991. 337: 582583.
  • 8
    Annane, D., Sebille, V., Charpentier, C., Bollaert, P. E., Francois, B., Korach, J. M., Capellier, G. et al., Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Jama 2002. 288: 862871.
  • 9
    Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R. et al., MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993. 365: 756759.
  • 10
    Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A. and Bucala, R., MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995. 377: 6871.
  • 11
    Calandra, T. and Roger, T., Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003. 3: 791800.
  • 12
    Bacher, M., Meinhardt, A., Lan, H. Y., Mu, W., Metz, C. N., Chesney, J. A., Calandra, T. et al., Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 1997. 150: 235246.
  • 13
    Nishino, T., Bernhagen, J., Shiiki, H., Calandra, T., Dohi, K. and Bucala, R., Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol. Med. 1995. 1: 781788.
  • 14
    Calandra, T., Bernhagen, J., Mitchell, R. A. and Bucala, R., The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 1994. 179: 18951902.
  • 15
    Calandra, T., Spiegel, L. A., Metz, C. N. and Bucala, R., Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Sci. USA 1998. 95: 1138311388.
  • 16
    Roger, T., David, J., Glauser, M. P. and Calandra, T., MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001. 414: 920924.
  • 17
    Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J. and Bucala, R., Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 2002. 99: 345350.
  • 18
    Mitchell, R. A., Metz, C. N., Peng, T. and Bucala, R., Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 1999. 274: 1810018106.
  • 19
    Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger-Kentischer, A., Flieger, O., Johannes, F. J. et al., Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000. 408: 211216.
  • 20
    Camps, M., Nichols, A. and Arkinstall, S., Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 2000. 14: 616.
  • 21
    Karin, M., Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs. Ann. Rheum. Dis. 2004. 63 Suppl 2: ii62ii64.
  • 22
    Theodosiou, A. and Ashworth, A., MAP kinase phosphatases. Genome Biol. 2002. 3: REVIEWS3009.
  • 23
    Charles, C. H., Abler, A. S. and Lau, L. F., cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene 1992. 7: 187190.
  • 24
    Charles, C. H., Sun, H., Lau, L. F. and Tonks, N. K., The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA 1993. 90: 52925296.
  • 25
    Sun, H., Charles, C. H., Lau, L. F. and Tonks, N. K., MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993. 75: 487493.
  • 26
    Chen, P., Li, J., Barnes, J., Kokkonen, G. C., Lee, J. C. and Liu, Y., Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 2002. 169: 64086416.
  • 27
    Engelbrecht, Y., de Wet, H., Horsch, K., Langeveldt, C. R., Hough, F. S. and Hulley, P. A., Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 2003. 144: 412422.
  • 28
    Kassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M. and Cato, A. C., Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001. 20: 71087116.
  • 29
    Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J. and Clark, A. R., Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell Biol. 2002. 22: 78027811.
  • 30
    Beishuizen, A., Thijs, L. G., Haanen, C. and Vermes, I., Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J. Clin. Endocrinol. Metab. 2001. 86: 28112816.
  • 31
    Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hultner, L., Heumann, D. et al., Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 2000. 6: 164170.
  • 32
    Akira, S. and Takeda, K., Toll-like receptor signaling. Nat. Rev. Immunol. 2004. 4: 499511.
  • 33
    Beutler, B., Inferences, questions and possibilities in Toll-like receptor signaling. Nature 2004. 430: 257263.
  • 34
    Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D. et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998. 282: 20852088.
  • 35
    Hermoso, M. A., Matsuguchi, T., Smoak, K. and Cidlowski, J. A., Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol. Cell Biol. 2004. 24: 47434756.
  • 36
    Li, Q. and Verma, I. M., NF-kappaB regulation in the immune system. Nat. Rev. Immuno.l 2002. 2: 725734.
  • 37
    Schaaf, M. J. and Cidlowski, J. A., Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mo. Biol. 2002. 83: 3748.
  • 38
    Zhang, T., Kruys, V., Huez, G. and Gueydan, C., AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem. Soc. Trans. 2002. 30: 952958.
  • 39
    Bevilacqua, A., Ceriani, M. C., Capaccioli, S. and Nicolin, A., Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J. Cell Physiol. 2003. 195: 356372.
  • 40
    Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. and Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995. 270: 286290.
  • 41
    Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. and Baldwin, A. S., Jr., Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995. 270: 283286.
  • 42
    Daun, J. M. and Cannon, J. G., Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000. 279: R10431049.
  • 43
    Shepherd, E. G., Zhao, Q., Welty, S. E., Hansen, T. N., Smith, C. V. and Liu, Y., The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J. Biol. Chem. 2004. 279: 5402354031.
  • 44
    Zhao, Q., Shepherd, E. G., Manson, M. E., Nelin, L. D., Sorokin, A. and Liu, Y., The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J. Biol. Chem. 2005. 280: 81018108.
  • 45
    Lasa, M., Mahtani, K. R., Finch, A., Brewer, G., Saklatvala, J. and Clark, A. R., Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell Biol. 2000. 20: 42654274.
  • 46
    Bernhagen, J., Mitchell, R. A., Calandra, T., Voelter, W., Cerami, A. and Bucala, R., Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994. 33: 1414414155.
  • 47
    Roger, T., Miconnet, I., Schiesser, A. L., Kai, H., Miyake, K. and Calandra, T., Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem. J. 2005. 387: 355365.